What's new in diuretic therapy.
A
A
Greenberg
D000086:Acetazolamide / Q000627:therapeutic use; D000137:Acid-Base Imbalance / Q000139:chemically induced; D001692:Biological Transport / Q000187:drug effects; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006947:Hyperkalemia / Q000139:chemically induced; D006955:Hypernatremia / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D007010:Hyponatremia / Q000139:chemically induced; D007190:Indapamide / Q000627:therapeutic use; D007686:Kidney Tubules, Distal / Q000187:drug effects; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000502:physiology; D008138:Loop of Henle / Q000187:drug effects; D008788:Metolazone / Q000627:therapeutic use; D009994:Osmolar Concentration; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014667:Vasopressins / Q000627:therapeutic use
D004232:Diuretics; D006852:Hydrochlorothiazide; D014667:Vasopressins; D013148:Spironolactone; D005665:Furosemide; D007190:Indapamide; D004976:Ethacrynic Acid; D000086:Acetazolamide; D008788:Metolazone; D014223:Triamterene